Bio-Bridge Science, Inc. - Product Pipeline Review - Q1 2011

Date: May 1, 2011
Pages: 28
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B06928A37E7EN
Leaflet:

Download PDF Leaflet

Bio-Bridge Science, Inc. - Product Pipeline Review - Q1 2011
Bio-Bridge Science, Inc. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Bio-Bridge Science, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • Bio-Bridge Science, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Bio-Bridge Science, Inc. human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Bio-Bridge Science, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Bio-Bridge Science, Inc.’s pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Evaluate Bio-Bridge Science, Inc.’s strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Bio-Bridge Science, Inc. in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Bio-Bridge Science, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Bio-Bridge Science, Inc..
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Bio-Bridge Science, Inc. and identify potential opportunities in those areas.
Table of Contents
List of Tables
List of Figures
Bio-Bridge Science, Inc. Snapshot
Bio-Bridge Science, Inc. Overview
Key Information
Key Facts
Bio-Bridge Science, Inc. – Research and Development Overview
Key Therapeutic Areas
Bio-Bridge Science, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Bio-Bridge Science, Inc. – Pipeline Products Glance
Bio-Bridge Science, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Bio-Bridge Science, Inc. – Drug Profiles
Colon Cancer Vaccine
Product Description
Mechanism of Action
R&D Progress
HIV-PV Vaccine I
Product Description
Mechanism of Action
R&D Progress
HPV Vaccine
Product Description
Mechanism of Action
R&D Progress
Bio-Bridge Science, Inc. – Pipeline Analysis
Bio-Bridge Science, Inc. – Pipeline Products by Therapeutic Class
Bio-Bridge Science, Inc. - Pipeline Products By Target
Bio-Bridge Science, Inc. – Pipeline Products by Route of Administration
Bio-Bridge Science, Inc. – Pipeline Products by Molecule Type
Bio-Bridge Science, Inc. – Company Statement
Bio-Bridge Science, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Bio-Bridge Science, Inc., Deals Summary, 2004 to 2011
Bio-Bridge Science, Inc. Detailed Deal Summary
Asset Purchase
Huhhot Xinheng Baide Biotechnology Acquires A Raw Bovine Serum Collection Center
Bio-Bridge Science Forms Joint Venture With JR Scientific And Other Investors
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Bio-Bridge Science, Inc. – Pipeline by Therapy Area and Indication, 2011
Bio-Bridge Science, Inc. – Pipeline by Stage of Development, 2011
Bio-Bridge Science, Inc. – Monotherapy Products in Pipeline, 2011
Bio-Bridge Science, Inc. - Pipeline By Therapeutic Class, 2011
Bio-Bridge Science, Inc. - Pipeline By Target, 2011
Bio-Bridge Science, Inc. – Pipeline By Route of Administration, 2011
Bio-Bridge Science, Inc. – Pipeline By Molecule Type, 2011
Bio-Bridge Science, Inc., Subsidiaries
Bio-Bridge Science, Inc., Deals Summary, 2004 to 2011

LIST OF FIGURES

Bio-Bridge Science, Inc. – Pipeline by Therapy Area and Indication, 2011
Bio-Bridge Science, Inc. – Pipeline by Stage of Development, 2011
Bio-Bridge Science, Inc. – Monotherapy Products in Pipeline, 2011
Bio-Bridge Science, Inc. – Pipeline By Therapeutic Class, 2011

Ask Your Question

Bio-Bridge Science, Inc. - Product Pipeline Review - Q1 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: